Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer... (eron CCEL Therapeutics Inc. and co-autho...)

Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer's Disease

Date:3/27/2008

eron CCEL Therapeutics, Inc. and co-author on the study. "Research suggests that we will continue to find positive outcomes from these cell therapies in this and other related diseases that are in need of significant therapeutic options."

Cryo-Cell offers an umbilical cord blood storage service to the public called U-Cord(R), in which cord blood stem cells are processed and cryogenically preserved in a safe and secure, state-of-the-art environment. Expectant parents receive a U-Cord Collection Kit when they are ready to give birth. Immediately after the baby is born and the umbilical cord is clamped and cut, the health professional uses a blood collection bag to draw blood from the umbilical cord. This process is painless and poses no risk to baby or mother.

Cryo-Cell tests the blood for infectious diseases and microbiological contamination to ensure that it is safe for future use. The cells are then prepared for long-term storage through a technique called controlled-rate freezing. Research has shown the cells are viable after 15 years, but stored cells are available for immediate use if needed. Every Cryo-Cell sample used for transplantation has been viable after thawing and dozens have been used in successful transplants to treat life-threatening conditions.

About Cryo-Cell International, Inc. (OTC Bulletin Board: CCEL.OB)

Based in Oldsmar, Florida, with over 150,000 clients worldwide, Cryo-Cell is one of the largest and most established family cord blood banks. ISO 9001:2000 certified and accredited by the AABB, Cryo-Cell operates in a state- of-the-art Good Manufacturing Practice and Good Tissue Practice (cGMP/cGTP)- compliant facility. Cryo-Cell is a publicly traded company. OTC Bulletin Board Symbol: CCEL. For more information, please call 1-800-STOR-CELL (1-800-786- 7235) or visit http://www.cryo-cell.com.

Forward-Looking Statement

Statements wherein the terms "bel
'/>"/>

0

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF
2. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
3. Clinical Trial Best Practices: Savvy Marketers Plan Ahead with Early Communication Strategies
4. New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline
5. PLC Systems Achieves Successful Early Conclusion of RenalGuard(TM) Pilot Safety Trial
6. Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection
7. New Data from the Framingham Heart Study Supports PAT Technology to Diagnose Early Cardiovascular Disease
8. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
9. Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia
10. Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development
11. Potential Early Warning System for Lung Cancer Identified

Post Your Comments:

Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer...(eron CCEL Therapeutics Inc. and co-autho...),Health